Ad-hoc | 3 May 2006 07:30

Fresenius Medical Care AG & Co. KGaA:Fresenius Medical Care reports First Quarter 2006 results

Ad hoc announcement transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— Fresenius Medical Care reports First Quarter 2006 results Fresenius Medical Care AG & Co. KGaA (“the Company”) today announces its results for the first quarter 2006. Net revenue was $1,747 million, up 9% compared to the first quarter 2005. Adjusted for currency, net revenue rose 10%. Excluding costs related to the change of accounting principles for stock options (SFAS 123R) and one-time costs associated with the transformation of Fresenius Medical Care’s legal form into a KGaA and related legal fees of $3 million, operating income (EBIT) increased by 12% to $247 million, resulting in an operating margin of 14.2%. On a comparable basis (excluding one-time costs and SFAS 123R), net income increased by 18% to $127 million. For the first quarter 2006, earnings per ordinary share rose by 7% to $1.19. The weighted average number of shares outstanding for the first quarter of 2006 was approximately 97.8 million shares. In the first quarter of 2006, the Company generated $162 million in net cash from operations. A total of $65 million (net of disposals) was spent for capital expenditures. Free Cash Flow before acquisitions was $97 million. The Free Cash Flow after acquisitions excluding the RCG acquisition increased by 14% to $87 million. Including the RCG acquisition, a total of $3,951 million in cash was used for acquisitions. For the year 2006, the Company confirms its outlook and expects to report revenue of more than $8 billion and reported net income for 2006 to be between $515 million and $535 million. Guidance provided by the Company does not take into effect any expected one-time items and the change of accounting principle for stock options – SFAS 123(R) in the fiscal year 2006. The Company expects the after tax impact of the one-time items and SFAS 123(R) to be around $60 million for the full year 2006. Fresenius AG (WKN 578560, 578563) holds approximately 37% of Fresenius Medical Care AG & Co. KGaA’s capital. Fresenius Medical Care AG & Co. KGaA, Represented by Fresenius Medical Care Management AG, Board of Management, Bad Homburg v.d.H., May 03, 2006 (c)DGAP 03.05.2006 ————————————————————————— language: English emitter: Fresenius Medical Care AG & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Deutschland phone: +49 (0) 6172- 609 2525 fax: +49 (0) 6172- 609 2301 email: ir@fmc-ag.com WWW: www.fmc-ag.de ISIN: DE0005785802, DE0005785836, WKN: 578580, 578583 indexes: DAX stockmarkets: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-Bremen, Hannover, Stuttgart, München, Hamburg, Düsseldorf; Foreign Exchange(s) NYSE End of News DGAP News-Service —————————————————————————